FDA Approves Xhance
Optinose Announces FDA Approval of Xhance (fluticasone propionate) Nasal Spray for the Treatment of Nasal Polyps
Optinose Announces FDA Approval of Xhance (fluticasone propionate) Nasal Spray for the Treatment of Nasal Polyps
FRIDAY, Sept. 22, 2017 -- Falls arent the only danger for kids who ride an off-road vehicle. In many parts of the United States, riders may also inhale hazardous mineral fibers and toxic dust, researchers warn. Four-wheel-drive and all-terrain vehicles
Are Her Chocolate Cravings a Product of the Culture?‘ FRIDAY, Aug. 25, 2017 -- While some U.S. women believe they need a dose of chocolate because their period is near, the culture they live in may be key to that impulse, new research suggests.
FDA Approves Gocovri (amantadine) for the Treatment of Dyskinesia in Parkinsons Disease Patients EMERYVILLE, Calif., Aug. 24, 2017 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that the U.S. Food and Drug Administration (
FDA Approves Besponsa FDA Approves Besponsa (inotuzumab ozogamicin) for Relapsed or Refractory Acute Lymphoblastic Leukemia
FRIDAY, Aug. 18, 2017 -- Researchers say one dose of cholera vaccine appears to provide about the same protection as the standard two doses, at least for the first six months. They also found that cholera vaccines are highly effective in adults but les